戻る
化工社化工社 化学情報印刷レポート · 研究参考用
HRID 37356作成日:2026年10月24日

4-Methylmorpholine → 6-[(8-chlorodibenz[b,f][1,4]oxazepin-10(11H)-yl)carbonyl]-N-(4-pyridinylmethyl)-2-pyridinecarboxamide, hydrochloride

https://huagongshe.com/ja/reaction/37356

反応式

関与物質

役割名称HCID仕込み量
反応物4-MethylmorpholineHCID 7972—
反応物4-PyridinemethanamineHCID 77317—
反応物2,6-Pyridinedicarbonyl dichlorideHCID 77335—
反応物8-Chloro-dibenz[b,f]-[1,4]oxazepineHCID 838267—
溶媒ChloroformHCID 6212—
生成物6-[(8-chlorodibenz[b,f][1,4]oxazepin-10(11H)-yl)carbonyl]-N-(4-pyridinylmethyl)-2-pyridinecarboxamide, hydrochlorideHCID 131719014—

反応手順

A solution of 8-chloro-dibenz[b,f][1,4]oxazepine (0.77 g), 2,6-pyridine-dicarbonyl chloride (0.68 g) and 4-methylmorpholine (0.367 mL) in CHCl3 (33 mL) was allowed to stand at ambient temperature for 16 hours. To this solution was added 4-(aminomethyl)pyridine (0.34 mL) and the mixture was allowed to stand at ambient temperature for 16 hours. The mixture was concentrated and the residue was extracted with ethyl acetate and saturated NaHCO3. The organic extract was concentrated and the residue chromatographed over silica gel using 50% ethyl acetate in hexane. Appropriate fractions were pooled and concentrated to give the free base of the title compound as a white solid. The HCl salt of the free base was made as described in Example 3.

情報源と証拠

DOI10.6084/m9.figshare.5104873.v1
特許番号US05420270
出典データセットuspto-grants-1995_05
ORD IDord-f8ddeab8d46441a4b8fa8589c29649fd
出典メモuspto-grants-1995_05